More Business Wire
View Older Stories View Newer Stories-
US Foods Announces Private Offering of $500 Million of Senior Unsecured Notes
-
KB Home Announces the Grand Opening of Its Newest Community in Highly Desirable Southwest Las Vegas
-
CIM Real Assets & Credit Fund Announces Monthly Dividends
-
Astria Therapeutics to Present at Upcoming Global Angioedema Forum
-
Reviving History: Shadowdock at the Birthplace of Titanic
-
Moving iMage Technologies Announces Fourth Quarter and Full Year Fiscal 2024 Results
-
Generate Capital Expands Leadership with Industry Experts
-
Covalon Technologies Ltd. to Participate in the 2024 Association for Vascular Access Annual Scientific Meeting
-
Septerna Announces Initiation of Phase 1 Clinical Trial with SEP-786, a Novel Oral Small Molecule PTH1R Agonist for the Treatment of Hypoparathyroidism
-
Flow Beverage Corp. to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024
-
Marqeta to Announce Third Quarter 2024 Results on November 4, 2024
-
Endpoints News Announces the 2024 Winners of the Endpoints 11 Awards, Highlighting Biotech’s Most Promising Startups
-
Survey Reveals Exercise is Key Outlet for Americans’ Growing Election Anxiety
-
Macedonian Thrace Brewery: European Court of Justice Opinion States Heineken HQ Has to Answer for the Market Abuses of Its Greek Subsidiary
-
Caresyntax Awarded 2024 German AI Prize for Advancing Surgical Intelligence
-
LEO Pharma Submits New Drug Application for Enstilar® for Adults with Plaque Psoriasis in China
-
Nextdoor Celebrates 2024 Neighborhood Fave Businesses Ahead of Holiday Shopping Season
-
InfuSystem to Participate in Lytham Partners Fall 2024 Investor Conference on October 1, 2024
-
Ault Disruptive Technologies Corporation Will Redeem Its Public Shares and Will Not Consummate an Initial Business Combination
-
Viamedia Appoints Former Ampersand Chief Operating Officer Ken Little to Board of Directors, Bolstering Strategic Leadership
-
ICON plc Schedules Third Quarter 2024 Earnings Conference Call
-
World Heart Day, 29 September 2024: Cardiovascular Health Risks: International SOS Shares Proactive Measures for Workplace Wellness
-
Northern Trust Survey Reveals the Importance of Emerging Technology in the Data Landscape
-
Tikehau Capital: Disclosure of Shares Repurchases from 20 September 2024 to 26 September 2024
-
ONERugged Unveils Rugged Outdoor Series: The Ideal Rugged Phones and Tablets for Outdoor Enthusiasts
-
Quality Collision Group Partners With Cana Capital to Construct New Stuart’s Paint & Body in Grapevine, Texas
-
IonQ Announces Largest 2024 U.S. Quantum Contract Award of $54.5M with United States Air Force Research Lab
-
Simplement Announces Optimized SAP to Microsoft Fabric Solution
-
Wolters Kluwer Launches CCH iFirm Validate Accelerating the Audit Process With Blockchain-Driven Validation and Confirmation
-
Geoquip Marine Appoints Rune Olav Pedersen as CEO
-
SES Confirms Interim Dividend of EUR 0.25
-
U.S.A.: TotalEnergies Enhances Gas Value Chain Integration by Acquiring Producing Assets in the Eagle Ford Basin
-
PureTech-Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in Adults
-
TME Pharma Provides Results of Third Exercise of Warrants Z
-
Final Real-World Results from MILOS German Cohort Demonstrate Strong Increase in LDL-C Goal Achievement With Addition of Bempedoic Acid
-
Claranova: Group Management Capitalizes on Future
-
Kioxia and MoDeCH Develop a Three-Dimensional Probing System
-
MeridianLink Announces Pricing of Secondary Offering of Common Stock
-
The hit zombie action comic achieving 8.5 million downloads in Japan, “In a World Full of Zombies I’m the Only One Who Doesn’t Get Attacked” will be available in English exclusively on MangaPl
-
Pagaya Announces Pricing of Upsized $140 Million Exchangeable Senior Notes Offering at a 45% Exchange Premium
-
Elepay Clears ASIC Audit, Strengthening Commitment to Compliance and Customer Protection
-
U.S. Food and Drug Administration Approves Bristol Myers Squibb’s COBENFY™ (xanomeline and trospium chloride), a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults
-
New Published Data Show Reproducibility and Utility of Perspectum’s MRI in Patients With Metabolic Liver Disease
-
Relo Reserve Revolutionizes Moving with Digital Marketplace and Strategic Real Estate Partnerships
-
Morris Industries Founder Nate Morris Delivers Keynote at Liberty University CEO Summit
-
BeiGene Provides Update on FDA Advisory Committee Vote on Benefit-Risk Profile of PD-1 Inhibitors, including TEVIMBRA®, for Treatment of ESCC and Gastric/GEJ Cancers
-
CION Investment Corporation Announces Pricing of Public Offering of Unsecured Notes Due 2029
-
Marti Technologies, Inc. to Report 2024 First Half Results on September 30, 2024
-
BGSF Named as an SAP Services Partner to Drive Digital Transformation and Innovation
-
Chillz U.S. Acquires Event-Tech Platform WYA, Expanding Presence in U.S. Event Market
